Blood Cancer Journal-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=1208261, encodeId=309812082616a, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：速度很快，投稿后第二天送审，3周外审意见返回。感觉对国人要求会严格很多，大修4个月，补了动物实验，修回后很快接收了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=334, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=53c94745681, createdName=chennianci0223, createdTime=Sat Apr 02 22:36:28 CST 2022, time=2022-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2123608, encodeId=86a3212360807, content=各位大神，请教一下该杂志接受病例报道吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=271, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTL8GV06roPeF96gmNNe5qicpI81qEbXLy1oKu8HDafssvuSfccR9UQIFkFFESxJ0ECOjgVoAt6QlaQ/132, createdBy=50201623070, createdName=wylj, createdTime=Tue Apr 04 06:34:55 CST 2023, time=2023-04-04, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=558035, encodeId=e18355803522, content=曾经投一个文章.建议改为letter发表.结果想发个全文.国人的理念还是需要改变一些!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=603, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=454286381, createdName=Long123, createdTime=Sat Jun 16 00:00:00 CST 2018, time=2018-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547155, encodeId=205054e15526, content=涨得很快，很有潜力, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=630, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=143a2125472, createdName=1109181423_90765432, createdTime=Thu Sep 14 14:58:00 CST 2017, time=2017-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=512639, encodeId=bf0a51263942, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：Manuscript Withdrawn是什么意思呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=739, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=888247627, createdName=lindabj, createdTime=Fri Jun 19 06:22:00 CST 2015, time=2015-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=505761, encodeId=96d3505e6145, content=Blood Cancer Journal seeks to publish articles of the highest quality related to hematologic malignancies and related disorders. The Journal will consider for publication original research, reviews, guidelines and letters that are considered to be of high impact in the field. 水平是可以的，只是国内在上面发表的论文极少，知名度还不高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=658, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue Sep 02 09:03:00 CST 2014, time=2014-09-02, status=1, ipAttribution=)]

2022-04-02 chennianci0223

审稿速度:1.0 | 投稿命中率:50.0
经验分享：速度很快，投稿后第二天送审，3周外审意见返回。感觉对国人要求会严格很多，大修4个月，补了动物实验，修回后很快接收了。

334 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=1208261, encodeId=309812082616a, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：速度很快，投稿后第二天送审，3周外审意见返回。感觉对国人要求会严格很多，大修4个月，补了动物实验，修回后很快接收了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=334, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=53c94745681, createdName=chennianci0223, createdTime=Sat Apr 02 22:36:28 CST 2022, time=2022-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2123608, encodeId=86a3212360807, content=各位大神，请教一下该杂志接受病例报道吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=271, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTL8GV06roPeF96gmNNe5qicpI81qEbXLy1oKu8HDafssvuSfccR9UQIFkFFESxJ0ECOjgVoAt6QlaQ/132, createdBy=50201623070, createdName=wylj, createdTime=Tue Apr 04 06:34:55 CST 2023, time=2023-04-04, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=558035, encodeId=e18355803522, content=曾经投一个文章.建议改为letter发表.结果想发个全文.国人的理念还是需要改变一些!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=603, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=454286381, createdName=Long123, createdTime=Sat Jun 16 00:00:00 CST 2018, time=2018-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547155, encodeId=205054e15526, content=涨得很快，很有潜力, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=630, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=143a2125472, createdName=1109181423_90765432, createdTime=Thu Sep 14 14:58:00 CST 2017, time=2017-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=512639, encodeId=bf0a51263942, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：Manuscript Withdrawn是什么意思呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=739, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=888247627, createdName=lindabj, createdTime=Fri Jun 19 06:22:00 CST 2015, time=2015-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=505761, encodeId=96d3505e6145, content=Blood Cancer Journal seeks to publish articles of the highest quality related to hematologic malignancies and related disorders. The Journal will consider for publication original research, reviews, guidelines and letters that are considered to be of high impact in the field. 水平是可以的，只是国内在上面发表的论文极少，知名度还不高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=658, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue Sep 02 09:03:00 CST 2014, time=2014-09-02, status=1, ipAttribution=)]

2023-04-04 wylj 来自江苏省

各位大神，请教一下该杂志接受病例报道吗

271 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=1208261, encodeId=309812082616a, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：速度很快，投稿后第二天送审，3周外审意见返回。感觉对国人要求会严格很多，大修4个月，补了动物实验，修回后很快接收了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=334, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=53c94745681, createdName=chennianci0223, createdTime=Sat Apr 02 22:36:28 CST 2022, time=2022-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2123608, encodeId=86a3212360807, content=各位大神，请教一下该杂志接受病例报道吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=271, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTL8GV06roPeF96gmNNe5qicpI81qEbXLy1oKu8HDafssvuSfccR9UQIFkFFESxJ0ECOjgVoAt6QlaQ/132, createdBy=50201623070, createdName=wylj, createdTime=Tue Apr 04 06:34:55 CST 2023, time=2023-04-04, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=558035, encodeId=e18355803522, content=曾经投一个文章.建议改为letter发表.结果想发个全文.国人的理念还是需要改变一些!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=603, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=454286381, createdName=Long123, createdTime=Sat Jun 16 00:00:00 CST 2018, time=2018-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547155, encodeId=205054e15526, content=涨得很快，很有潜力, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=630, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=143a2125472, createdName=1109181423_90765432, createdTime=Thu Sep 14 14:58:00 CST 2017, time=2017-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=512639, encodeId=bf0a51263942, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：Manuscript Withdrawn是什么意思呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=739, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=888247627, createdName=lindabj, createdTime=Fri Jun 19 06:22:00 CST 2015, time=2015-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=505761, encodeId=96d3505e6145, content=Blood Cancer Journal seeks to publish articles of the highest quality related to hematologic malignancies and related disorders. The Journal will consider for publication original research, reviews, guidelines and letters that are considered to be of high impact in the field. 水平是可以的，只是国内在上面发表的论文极少，知名度还不高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=658, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue Sep 02 09:03:00 CST 2014, time=2014-09-02, status=1, ipAttribution=)]

2018-06-16 Long123

曾经投一个文章.建议改为letter发表.结果想发个全文.国人的理念还是需要改变一些!

603 0

[GetPortalCommentsPageByObjectIdResponse(id=1208261, encodeId=309812082616a, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：速度很快，投稿后第二天送审，3周外审意见返回。感觉对国人要求会严格很多，大修4个月，补了动物实验，修回后很快接收了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=334, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=53c94745681, createdName=chennianci0223, createdTime=Sat Apr 02 22:36:28 CST 2022, time=2022-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2123608, encodeId=86a3212360807, content=各位大神，请教一下该杂志接受病例报道吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=271, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTL8GV06roPeF96gmNNe5qicpI81qEbXLy1oKu8HDafssvuSfccR9UQIFkFFESxJ0ECOjgVoAt6QlaQ/132, createdBy=50201623070, createdName=wylj, createdTime=Tue Apr 04 06:34:55 CST 2023, time=2023-04-04, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=558035, encodeId=e18355803522, content=曾经投一个文章.建议改为letter发表.结果想发个全文.国人的理念还是需要改变一些!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=603, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=454286381, createdName=Long123, createdTime=Sat Jun 16 00:00:00 CST 2018, time=2018-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547155, encodeId=205054e15526, content=涨得很快，很有潜力, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=630, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=143a2125472, createdName=1109181423_90765432, createdTime=Thu Sep 14 14:58:00 CST 2017, time=2017-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=512639, encodeId=bf0a51263942, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：Manuscript Withdrawn是什么意思呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=739, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=888247627, createdName=lindabj, createdTime=Fri Jun 19 06:22:00 CST 2015, time=2015-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=505761, encodeId=96d3505e6145, content=Blood Cancer Journal seeks to publish articles of the highest quality related to hematologic malignancies and related disorders. The Journal will consider for publication original research, reviews, guidelines and letters that are considered to be of high impact in the field. 水平是可以的，只是国内在上面发表的论文极少，知名度还不高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=658, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue Sep 02 09:03:00 CST 2014, time=2014-09-02, status=1, ipAttribution=)]

2017-09-14 1109181423_90765432

涨得很快，很有潜力

630 0

[GetPortalCommentsPageByObjectIdResponse(id=1208261, encodeId=309812082616a, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：速度很快，投稿后第二天送审，3周外审意见返回。感觉对国人要求会严格很多，大修4个月，补了动物实验，修回后很快接收了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=334, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=53c94745681, createdName=chennianci0223, createdTime=Sat Apr 02 22:36:28 CST 2022, time=2022-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2123608, encodeId=86a3212360807, content=各位大神，请教一下该杂志接受病例报道吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=271, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTL8GV06roPeF96gmNNe5qicpI81qEbXLy1oKu8HDafssvuSfccR9UQIFkFFESxJ0ECOjgVoAt6QlaQ/132, createdBy=50201623070, createdName=wylj, createdTime=Tue Apr 04 06:34:55 CST 2023, time=2023-04-04, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=558035, encodeId=e18355803522, content=曾经投一个文章.建议改为letter发表.结果想发个全文.国人的理念还是需要改变一些!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=603, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=454286381, createdName=Long123, createdTime=Sat Jun 16 00:00:00 CST 2018, time=2018-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547155, encodeId=205054e15526, content=涨得很快，很有潜力, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=630, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=143a2125472, createdName=1109181423_90765432, createdTime=Thu Sep 14 14:58:00 CST 2017, time=2017-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=512639, encodeId=bf0a51263942, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：Manuscript Withdrawn是什么意思呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=739, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=888247627, createdName=lindabj, createdTime=Fri Jun 19 06:22:00 CST 2015, time=2015-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=505761, encodeId=96d3505e6145, content=Blood Cancer Journal seeks to publish articles of the highest quality related to hematologic malignancies and related disorders. The Journal will consider for publication original research, reviews, guidelines and letters that are considered to be of high impact in the field. 水平是可以的，只是国内在上面发表的论文极少，知名度还不高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=658, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue Sep 02 09:03:00 CST 2014, time=2014-09-02, status=1, ipAttribution=)]

2015-06-19 lindabj

审稿速度:1.0 | 投稿命中率:25.0
经验分享：Manuscript Withdrawn是什么意思呢

739 0

[GetPortalCommentsPageByObjectIdResponse(id=1208261, encodeId=309812082616a, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：速度很快，投稿后第二天送审，3周外审意见返回。感觉对国人要求会严格很多，大修4个月，补了动物实验，修回后很快接收了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=334, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=53c94745681, createdName=chennianci0223, createdTime=Sat Apr 02 22:36:28 CST 2022, time=2022-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2123608, encodeId=86a3212360807, content=各位大神，请教一下该杂志接受病例报道吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=271, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTL8GV06roPeF96gmNNe5qicpI81qEbXLy1oKu8HDafssvuSfccR9UQIFkFFESxJ0ECOjgVoAt6QlaQ/132, createdBy=50201623070, createdName=wylj, createdTime=Tue Apr 04 06:34:55 CST 2023, time=2023-04-04, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=558035, encodeId=e18355803522, content=曾经投一个文章.建议改为letter发表.结果想发个全文.国人的理念还是需要改变一些!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=603, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=454286381, createdName=Long123, createdTime=Sat Jun 16 00:00:00 CST 2018, time=2018-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547155, encodeId=205054e15526, content=涨得很快，很有潜力, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=630, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=143a2125472, createdName=1109181423_90765432, createdTime=Thu Sep 14 14:58:00 CST 2017, time=2017-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=512639, encodeId=bf0a51263942, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：Manuscript Withdrawn是什么意思呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=739, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=888247627, createdName=lindabj, createdTime=Fri Jun 19 06:22:00 CST 2015, time=2015-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=505761, encodeId=96d3505e6145, content=Blood Cancer Journal seeks to publish articles of the highest quality related to hematologic malignancies and related disorders. The Journal will consider for publication original research, reviews, guidelines and letters that are considered to be of high impact in the field. 水平是可以的，只是国内在上面发表的论文极少，知名度还不高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=658, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue Sep 02 09:03:00 CST 2014, time=2014-09-02, status=1, ipAttribution=)]

2014-09-02 匿名用户

Blood Cancer Journal seeks to publish articles of the highest quality related to hematologic malignancies and related disorders. The Journal will consider for publication original research, reviews, guidelines and letters that are considered to be of high impact in the field.

水平是可以的，只是国内在上面发表的论文极少，知名度还不高。

658 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务